Notably, as FIB-4 includes only indirect markers of liver damage (AST, ALT), risk factors (age) or portal hypertension (platelets), it is no direct marker of liver fibrosis and should not be used as only decision tool [8, 19]. The gene discussed is GPT; the disease is portal hypertension.